Surveys and Interviews to Support an Evaluation of the Innovative Molecular Analysis Technologies (IMAT) Program (NCI)

ICR 201503-0925-003

OMB: 0925-0720

Federal Form Document

Forms and Documents
Document
Name
Status
Form and Instruction
New
Form and Instruction
New
Form and Instruction
New
Supplementary Document
2015-03-09
Supplementary Document
2015-03-09
Supplementary Document
2015-03-09
Supplementary Document
2015-03-09
Supplementary Document
2015-03-09
Supporting Statement B
2015-03-09
Supporting Statement A
2015-03-09
ICR Details
0925-0720 201503-0925-003
Historical Active
HHS/NIH
Surveys and Interviews to Support an Evaluation of the Innovative Molecular Analysis Technologies (IMAT) Program (NCI)
New collection (Request for a new OMB Control Number)   No
Regular
Approved without change 05/29/2015
Retrieve Notice of Action (NOA) 03/10/2015
  Inventory as of this Action Requested Previously Approved
05/31/2016 12 Months From Approved
1,050 0 0
575 0 0
0 0 0

This request is to gain OMB approval for the new submission titled, "Surveys and Interviews to Support an Evaluation of the Innovative Molecular Analysis Technologies (IMAT) Program" for 1 year. The National Cancer Institute (NCI) IMAT program was launched in 1998 to support the development of highly innovative technologies to advance cancer research and clinical care capabilities. NCI is proposing to pursue a comprehensive and robust evaluation to assess the process and outcomes of the IMAT program, and also seek opportunities for NCI to improve the program's utility for the broad continuum of cancer researchers, clinicians and ultimately patients. The focus of the evaluation will be on understanding the successes of supported technologies and will occur with three respondent groups: IMAT awardees, a sample of awardees from NIH funded programs on technology development beyond the IMAT program, and technology end users. The evaluation approach is to be centered on tracking or following all supported technologies since 1998. To date, the IMAT program has issued 513 R21 and R33 awards and 160 SBIR and STTR awards, supporting roughly 500 unique technology platforms.

US Code: 42 USC 285 Name of Law: Public Health Service Act
  
None

Not associated with rulemaking

  79 FR 72004 12/04/2014
80 FR 12487 03/09/2015
No

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 1,050 0 0 1,050 0 0
Annual Time Burden (Hours) 575 0 0 575 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
Yes
Miscellaneous Actions
No
new submission

$149,570
No
No
No
No
No
Uncollected
Tawanda Abdelmouti 240 276-5530 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
03/10/2015


© 2024 OMB.report | Privacy Policy